Revisiting the role of bone-modifying agents in the management of metastatic prostate cancer
Author:
Affiliation:
1. Hong Kong Integrated Oncology Centre; Central Hong Kong
Funder
Amgen Asia Holding Limited
Publisher
Wiley
Subject
Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.13061/fullpdf
Reference23 articles.
1. Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer;Smith;Urology,2007
2. SEOM guidelines for the treatment of bone metastases from solid tumours;Cassinello Espinosa;Clin Transl Oncol,2012
3. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases;Ibrahim;Clin Cancer Res,2003
4. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial;Logothetis;Lancet Oncol,2012
5. Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial;Fizazi;Lancet Oncol,2014
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. α-lipoic acid modulates prostate cancer cell growth and bone cell differentiation;Scientific Reports;2024-02-22
2. Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases;Scientific Reports;2023-05-29
3. Hypocalcemia in a Patient With Metastatic Prostate Cancer From Denosumab Treatment;Cureus;2021-08-10
4. Bisphosphonates Versus Denosumab for Prevention of Pathological Fracture in Advanced Cancers With Bone Metastasis: A Meta-analysis of Randomized Controlled Trials;JAAOS: Global Research and Reviews;2020-08
5. miR-1231 Is Downregulated in Prostate Cancer with Prognostic and Functional Implications;Oncology Research and Treatment;2019-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3